Clinical Trials Logo

Filter by:
NCT ID: NCT00216476 Completed - Schizophrenia Clinical Trials

A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Start date: October 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate whether a long-acting injectable formulation of risperidone provides better effectiveness over 2 years, as measured by the time to relapse, compared with quetiapine tablets in a routine psychiatric care setting. Aripiprazole will be investigated in a descriptive manner.

NCT ID: NCT00215683 Completed - Prostate Cancer Clinical Trials

An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer

Start date: February 2005
Phase: Phase 2/Phase 3
Study type: Interventional

This was an extension study for the study FE200486 CS12 (NCT00819156). Each participant was to be treated until he was discontinued or withdrawn from the study, or a marketing authorization for degarelix had been obtained. The study was terminated when all ongoing participants had been treated for at least 5 years (including one year in the main study).

NCT ID: NCT00214578 Completed - Schizophrenia Clinical Trials

Seroquel on Glucose Metabolism

Start date: April 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether six months treatment with the antipsychotic medicine Seroquel (quetiapine) may affect the schizophrenic patient's glucose metabolism

NCT ID: NCT00211237 Completed - Cancer Clinical Trials

CAFE Study - Cancer Patient Fracture Evaluation

CAFE
Start date: May 2005
Phase: N/A
Study type: Interventional

The primary objective of this study is to evaluate the safety and effectiveness of balloon kyphoplasty treatment for painful, acute, vertebral compression fractures (VCFs) as compared to standard non-surgical therapy in patients with cancer.

NCT ID: NCT00207740 Completed - Asthma Clinical Trials

A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma

Start date: August 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and safety of CNTO 148 (golimumab) in patients with severe persistent asthma.

NCT ID: NCT00206310 Completed - Heart Failure Clinical Trials

Crestor Versus Placebo in Subjects With Heart Failure

Start date: September 2003
Phase: Phase 3
Study type: Interventional

The purpose of the study is to investigate if rosuvastatin, added on top of all other medicines prescribed to subjects with symptomatic systolic heart failure, reduces the combined endpoint of cardiovascular death or non-fatal myocardial infarction or non-fatal stroke (time to first event)

NCT ID: NCT00206167 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD

Start date: April 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare Symbicort in a pressurized metered-dose inhaler (pMDI) with formoterol and placebo in the long-term maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

NCT ID: NCT00206128 Completed - Schizophrenia Clinical Trials

Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia

Start date: November 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine that the efficacy of the sustained release (SR) formulation of quetiapine (Seroquel) is not inferior to the immediate release (IR) formulation. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

NCT ID: NCT00205777 Completed - Osteoporosis Clinical Trials

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

Start date: December 2001
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether bazedoxifene acetate is safe and effective in the treatment of osteoporosis in postmenopausal women.

NCT ID: NCT00202644 Completed - Clinical trials for Thrombocythemia, Hemorrhagic

A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients

Start date: January 13, 2006
Phase: Phase 4
Study type: Interventional

Essential thrombocythaemia is a disorder of bone marrow, which causes too many platelets to be produced. Platelets are small cells carried around in the blood, which help form blood clots. When patients have too many platelets, there is a risk of blood clots forming unnecessarily and excessive bleeding. The aim of this study is to gain additional information on the safety profile of Anagrelide (Xagrid(r)) and Hydroxyurea (also known as hydroxycarbamide).